Menopause treatment four times more common in wealthier areas

Hormone replacement therapy for menopausal symptoms is significantly more accessible in affluent areas of Sweden, with wealthier women four times more likely to receive estrogen treatment than those in poorer regions. This stark disparity in access has raised concerns among medical professionals.

Angelica Lindén Hirschberg, a professor specializing in the field, described the situation as "frightening." The data reveals a clear socioeconomic divide in the availability of treatments for menopausal symptoms, suggesting that financial status plays a crucial role in women's healthcare access.

The findings highlight a broader issue of healthcare inequality within Sweden. While the overall use of hormone therapy has increased, its distribution is uneven, leaving women in less privileged areas with fewer options for managing their menopausal health. This gap warrants further investigation and potential intervention to ensure equitable access to care.